| Stage | EXPO | % of rev | CRAI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $172M | 100.00% | $186M | 100.00% | CRAI ×1.08 |
| Gross profit | $71M | 41.40% | $54M | 29.28% | EXPO +12.1pp |
| Operating income | $28M | 16.33% | $17M | 9.26% | EXPO +7.1pp |
| Pre-tax income | $41M | 23.75% | $16M | 8.73% | EXPO +15.0pp |
| Net income | $29M | 17.13% | $11M | 6.17% | EXPO +11.0pp |
| Stage | EXPO | CRAI | Gap · A − B |
|---|---|---|---|
| Revenue | $172M100.00% | $186M100.00% | CRAI ×1.08 |
| Gross profit | 41.40%$71M | 29.28%$54M | EXPO +12.1pp |
| Operating income | 16.33%$28M | 9.26%$17M | EXPO +7.1pp |
| Pre-tax income | 23.75%$41M | 8.73%$16M | EXPO +15.0pp |
| Net income |
| 17.13%$29M |
| 6.17%$11M |
| EXPO +11.0pp |
No disclosed counterparties: CRAI.
None